Deal

NorInnova Invest acquires Calanus

Norinnova Invest has invested in Calanus AS and now owns 15,8 percent of the company.

Calanus, established in 2002, is developing new health and nutrition supplements, as well as specialty pharmaceutical preparations, based on the harvestable marine crustacean copepod (Calanus finmarchicus). The company also participates in the development of sustainable harvesting of the raw material. 

Read more

 

 


FundNorInnova Invest
Portfolio CompanyCalanus
Date of Transaction2009-12-10
TransactionAcquisition
Seller
Buyer
Size of Transaction 
Ind. FocusLife Science
GeographyNorway
StageSeed
 

More deals

(2011-07-13)